Patrick Soon-Shiong Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Professionals
  • 1

  • Investments
  • 7

  • Portfolio
  • 2

  • Exits
  • 3


Patrick Soon-Shiong General Information


Mr. Patrick Soon-Shiong is the Founder and serves as Chairman and Chief Executive Officer at Nantworks. Mr. Soon-Shiong serves as Chief Executive Officer and Chairman of the Board at NantHealth. He serves as Chief Executive Officer, Board Member and Managing Director at NantBioscience. He is the Founder and serves as Chief Executive Officer and Board Member at NantOmics. He served as Board Member at Keyssa. He has served as Chief Executive Officer and Chairman of our Board of Directors since NantHealth's founding in July 2010. A physician, surgeon and scientist, he has pioneered novel therapies for both diabetes and cancer, published more than 100 scientific papers, and has received over 95 patents on groundbreaking advancements spanning a myriad of fields. He served as Chairman at Altor BioScience. He is a Co-Founder and serves as Chairman at Tensorcom. He is an internationally recognized surgeon, scientist, inventor, and philanthropist with over 500 patents issued worldwide and the author of more than 100 peer-reviewed scientific publications. He serves as the Executive Chairman of ImmunityBio, a company he founded in 2014. He also serves as Chairman and the Chief Executive Officer of Nant Health (NASDAQ:NH), a transformational healthcare company converging biomolecular medicine and bioinformatics with deep learning AI. He is also the Owner and Executive Chairman of the Los Angeles Times and The San Diego Union-Tribune. He serves as Chairman of the Chan Soon-Shiong Family Foundation and of the Chan Soon-Shiong Institute of Molecular Medicine. Since the 1990s Dr. Soon-Shiong founded and led global pharmaceutical companies, American Pharmaceutical Partners and Abraxis BioScience, the latter of which is where he developed Abraxane, the first protein nanoparticle drug for breast, lung, and pancreatic cancer. The drug has achieved blockbuster status with annual sales exceeding a billion dollars and has now been acquired by Bristol Myers Squib. His contribution to the advancement in cancer treatment has been honoured by the Smithsonian National Museum of American History where Abraxane is now permanently housed, by the Friends of the National Library of Medicine Science with the Distinguished Medical Science award and by the Vatican with the Pontifical Key Visionary Award.

Contact Information

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • Los Angeles, CA
  • United States

Patrick Soon-Shiong Investments (7)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Sienza Energy 17-Feb-2022 Later Stage VC 0000 Electrical Equipment Generating Revenue 0000000 0000-000000 00
0000 00000 0000000 04-Feb-2015 00000 00000 0000 Communication Software Profitable 0000000 0000-000000 00
000000000 26-Dec-2014 00000 00000 0000 Drug Discovery Generating Revenue/Not Profitable 0000000 0000-000000 00
0000000000 13-May-2014 00000 00000 0000 Business/Productivity Software Startup 0000000 0000-000000 00
0000 00000 0000000 24-Sep-2013 00000 00000 00.000 Communication Software Profitable 0000000 0000-000000 00
Prizeo US 06-Jun-2013 Seed Round 00.00 Other Services (B2C Non-Financial) Generating Revenue 0000000 0000-000000 00
Zoom Video Communications 28-Jan-2013 Early Stage VC 000 Communication Software Profitable 0000000 0000-000000 00
To view Patrick Soon-Shiong’s complete investments history, request access »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Patrick Soon-Shiong Exits (3)

Company Name Exit Date Exit Type Exit Size
Zoom Video Communications 18-Apr-2019 IPO 00000
000000000 28-Jul-2015 000 00000
000000 00 23-Jun-2015 000000000000000000
To view Patrick Soon-Shiong’s complete exits history, request access »

Patrick Soon-Shiong Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Patrick Soon-Shiong Team (1)

Name Title Deals Funds Boards Office
Patrick Soon-Shiong MD Angel Investor 00 00 Los Angeles, CA
To view Patrick Soon-Shiong’s complete team members history, request access »